Kolexia
Chomel Jean-Claude Pharmacien
Chomel Jean-Claude
Pharmacien
Hôpital La Miletrie
Poitiers, France
94 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémie myéloïde chronique BCR-ABL positive Leucémies Leucémie myéloïde Crise blastique Leucémie aigüe myéloïde Thrombocytose Thrombocytémie essentielle Polyglobulie primitive essentielle Leucémie myéloïde en phase chronique

Collaborateurs

Voir plus
Turhan Ali
Turhan Ali
Cabinet libéral, Neuilly-sur-Seine, France
Bennaceur-Griscelli Annelise
Bennaceur-Griscelli Annelise
Hôpital Paul Brousse, Villejuif, France
Guilhot-Gaudeffroy Francois
Guilhot-Gaudeffroy Francois
CHU Poitiers, Poitiers, France
Cayssials-Caylus Emilie
Cayssials-Caylus Emilie
Hôpital La Miletrie, Poitiers, France

Industries

Voir plus
Celgene
1 collaboration(s)
Dernière en 2021
Novartis
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Emergence of secondary fusions in chronic myeloid leukemia as a driver of tyrosine kinase inhibitor resistance and blast crisis transformation.
Leukemia research   23 janvier 2024
Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with from Chronic Myeloid Leukemia (CML) in Blast Crisis.
International journal of molecular sciences   22 octobre 2023
Hairy cell leukemia with isolated bone lesions.
Clinical case reports   16 mai 2023
Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms.
British journal of haematology   14 mai 2023
ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia.
Turkish journal of haematology : official journal of Turkish Society of Haematology   07 avril 2023
Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs).
Cells   12 février 2023
Thrombosis with Non-Proliferative Complete Blood Count Indicative of Underlying Myeloproliferative Neoplasm, Sythrom, a Study on Behalf of the FIM Group
Annual Meeting Abstracts 2022   15 novembre 2022
Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets
Annual Meeting Abstracts 2022   15 novembre 2022
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
British journal of haematology   10 octobre 2022
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
Blood cancer journal   08 avril 2022